๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Purification and Characterization of Hyaluronan from Synovial Fluid

โœ Scribed by C. Kvam; D. Granese; A. Flaibani; F. Zanetti; S. Paoletti


Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
526 KB
Volume
211
Category
Article
ISSN
0003-2697

No coin nor oath required. For personal study only.

โœฆ Synopsis


An easy and rapid method for the purification and characterization of hyaluronan from synovial fluid has been developed. Lipids were removed by filtration through a hydrophobic filter prior to the removal of proteins by phenol-chloroform extraction. The hyaluronan recovery was (95 %), as measured by three different methods. The average molecular weight of hyaluronan did not change during the purification. Furthermore, it was found that an optimized enzymatic protein digestion of pathological human synovial fluid prior to filtration yielded up to five times more hyaluronan recovered. In addition, the molecular weight of hyaluronan from synovial fluid not digested with pronase (E) was apparently higher because of the presence of aggregates. After the purification of hyaluronan (ca. (15 \mathrm{~min}) ), a single size-exclusion chromatography step allowed the simultaneous determination of its concentration and the reasonable estimate of its average molecular weight and molecular weight distribution curve. The logarithm of the molecular weight showed a linear dependence on the size-exclusion chromatography elution volume for hyaluronan in the molecular weight range (\mathbf{2 . 0}) (\times 10^{6}-1.0 \times 10^{4}). The removal of proteins allowed the determination of fairly low-molecular-weight fractions of hyaluronan, compared to untreated samples for which hyaluronan and protein peaks partially overlap. (C) 1993 Academic Press, Inc.


๐Ÿ“œ SIMILAR VOLUMES


Circulating and synovial fluid hyalurona
โœ Andrew A. Pitsillides; Robert K. Will; Michael T. Bayliss; JO C. W. Edwards ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 771 KB

To assess the effect of intraarticular (IA) corticosteroid on hyaluronan (HA) concentrations in synovial fluid (SF) and serum and the clearance of '311-labeled albumin from the joints of patients with rheumatoid arthritis (RA), osteoarthritis (OA), and ankylosing spondylitis (AS). Methods. SF and s